InvestorsHub Logo
Followers 43
Posts 9124
Boards Moderated 0
Alias Born 01/06/2011

Re: Lemmiwinks post# 333984

Thursday, 04/08/2021 3:29:44 PM

Thursday, April 08, 2021 3:29:44 PM

Post# of 427141
I have my doubts it will behave like a vaccine and prevent COVID infections. It certainly will reduce side effects of COVID, from experience. Secondary end point may do well. I believe Vascepa prevented me from getting a sever case of the disease.

Percentage of SARS-CoV-2 positive subjects [ Time Frame: 60 days ]
SARS-CoV-2 positive subjects are defined as subjects with positive tests for SARS-CoV-2 RT-PCR or for SARS-CoV-2 lgG antibodies after developing COVID-19 disease at any stage within the follow-up period (including those subjects with or without symptomatic COVID-19 evaluated before the final visit) or those individuals who test positive for SARS-CoV-2 RT-PCR or for SARS-CoV-2 lgG antibodies at the final visit (day 60).

Highest mean WHO descriptive score of COVID-19 in the active treatment group compared to the placebo group. [ Time Frame: 60 days ]
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News